Atul Limited has informed the Exchange that Record date for the purpose of DI is 17-Jul-2026.

Pat Growth 25pctResults View source PDF Explain this filing

ATUL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹6694.00

prior close

₹6806.00

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.1%+0.4% vs market

Specialty Chemicals peers, median of 93sector-1.3%+0.7% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Smallcap 250 and 0.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

+1.4

15m

+0.4

30m

+0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.1+0.4-1.3+0.7

Next day

+0.1+0.7-0.6+0.0+0.1

+2.8+0.8+2.0-0.2+3.0

+1.2+1.3-0.0-0.5+1.7

+2.0+0.8+1.1-0.1+2.0

+3.9+1.8+2.1+1.1+2.8

+6.2+3.9+2.3+2.2+4.0

15d

+2.8-0.7+3.5-1.4+4.2

+4.7+2.3+2.3+1.9+2.7

-1.1+7.2-8.3+3.0-4.1

-3.0+6.1-9.1+1.5-4.6

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 93Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Atul Limited reported strong full-year results for FY2026. Consolidated revenue grew 12.4% to ₹6,273.54 crore from ₹5,583.35 crore, while profit after tax surged 38.2% to ₹689.39 crore from ₹498.83 crore. Standalone PAT grew 30.4% to ₹595.04 crore. EPS improved to ₹230.25 (consolidated) and ₹202.11 (standalone). The Board proposed a dividend of ₹30 per share (300%), with record date July 17, 2026 and payment after August 5, 2026. Statutory auditors Deloitte Haskins & Sells LLP issued unmodified (clean) opinions on both standalone and consolidated financial results. Key segments include Life Science Chemicals and Performance and Other Chemicals.

Likely market impact

Strong financial performance with PAT growth exceeding 25% threshold, driven by robust revenue growth and margin improvement. Clean audit opinion supports financial integrity. Dividend declaration is positive for shareholders.